Contributors

Hans Kristian Kotlar began his career as a cancer researcher and says he was "the last idealist who left to turn industrialist." His professed "love of a pretty woman" lured him to another part of Norway, where ended up using his early training in polymer chemistry to work for StatoilHydro, the Norwegian state oil company which chiefly operates in the North Sea. Now the head of StatoilHydro's

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hans Kristian Kotlar began his career as a cancer researcher and says he was "the last idealist who left to turn industrialist." His professed "love of a pretty woman" lured him to another part of Norway, where ended up using his early training in polymer chemistry to work for StatoilHydro, the Norwegian state oil company which chiefly operates in the North Sea. Now the head of StatoilHydro's R&D, he looks for interesting microorganisms in oil deposits under the North Sea, which he describes in "Can Bacteria Rescue the Oil Industry?".

As a graduate student, James Lyons-Weiler was asked if bioinformatics was a fad or was something real. Intrigued, he investigated and became hooked. In this month's opinion ("Time for an IP Share Market?"), Lyons-Weiler argues that investors should put their money towards specific intellectual property, not just the companies that own it. The idea came because of "my interaction with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies